Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03567889
Title Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients (Neo-DREAM)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Philogen S.p.A.
Indications

melanoma

Therapies

Daromun

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.